Literature DB >> 2873344

Ribavirin enters cerebrospinal fluid.

C Crumpacker, G Bubley, D Lucey, S Hussey, J Connor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2873344     DOI： 10.1016/s0140-6736(86)92590-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.

Authors:  E G Sandström; J C Kaplan
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

Review 2.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

3.  Effective ribavirin concentration in hamster brains for antiviral chemotherapy for subacute sclerosing panencephalitis.

Authors:  T Ishii; M Hosoya; S Mori; S Shigeta; H Suzuki
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

4.  Mechanism of La Crosse virus inhibition by ribavirin.

Authors:  L F Cassidy; J L Patterson
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

5.  Pharmacokinetics of ribavirin aerosol in mice.

Authors:  B E Gilbert; P R Wyde
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

6.  The time-course of ribavirin-provoked changes of basal and AMPH-induced motor activities in rats.

Authors:  Branka Janać; Vesna Pesić; Sanja Peković; Ljubisav Rakić; Mirjana Stojiljković
Journal:  Exp Brain Res       Date:  2005-05-10       Impact factor: 1.972

7.  Failure of interferon alfa and tribavirin in rabies encephalitis.

Authors:  M J Warrell; N J White; S Looareesuwan; R E Phillips; P Suntharasamai; P Chanthavanich; M Riganti; S P Fisher-Hoch; K G Nicholson; S Manatsathit
Journal:  BMJ       Date:  1989-09-30

8.  Aerosol and intraperitoneal administration of ribavirin and ribavirin triacetate: pharmacokinetics and protection of mice against intracerebral infection with influenza A/WSN virus.

Authors:  B E Gilbert; P R Wyde; S Z Wilson; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

9.  Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection.

Authors:  E Connor; S Morrison; J Lane; J Oleske; R L Sonke; J Connor
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

Review 10.  Comparative pharmacokinetics of antiviral nucleoside analogues.

Authors:  G D Morse; M J Shelton; A M O'Donnell
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.